/

AVTX

Avalo Therapeutics, Inc.Pre-market

12.01−1.23 −9.29%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayPre-market 12.02 +0.08%

Open

13.23

Prev close

13.24

Day range

11.9913.23

52-week range

11.9924.27

Volume

1.65M1.79×

Mkt cap

644.10M

P/E ttm

—

Fwd P/E

-4.43

EPS ttm

-4.31

Div yield

0.00%

Earnings

Aug 6, 2026

From 52w high

−50.52%

Price Chart

Yahoo Finance · delayed

AVTXOct 13, 2026O 13.23H 13.23L 11.99C 12.01−1.23 (−9.29%)Vol 1.65M

SMA 5017.40
SMA 20016.54

1Y change −12.14% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

AVTX Avalo Therapeutics, Inc. · Last Guard Finance

SEAS

Seasonality · AVTX

2015–2026 · monthly returns

Strongest month Mar +32.30%Weakest month Apr −8.75%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-16.8	15.8	-14.7	-10.2	19.0	15.9	-1.2	6.0	-20.7	-21.7			−33.9%
2025	13.3	-13.2	9.6	-37.8	-19.7	24.7	58.1	17.7	36.8	41.9	5.4	-4.4	+144.4%
2024	-48.9	-5.2	393.2	-21.3	-31.7	6.7	-8.7	-38.5	35.7	36.9	-26.6	-22.2	−18.4%
2023	-21.7	-36.1	-30.6	66.3	-1.4	-87.6	-43.7	-50.0	21.0	-9.1	-36.4	-45.8	−99.2%
2022	-42.2	-25.7	-0.7	-43.3	-12.4	38.9	-40.0	31.9	-30.1	80.7	-8.9	-7.8	−75.3%
2021	19.3	7.0	-10.4	4.0	-15.9	23.9	-18.7	16.5	-29.7	7.3	-14.5	-15.0	−35.6%
2020	-26.7	-22.8	-18.7	-4.4	36.3	-19.5	5.0	-9.9	-7.5	-9.5	21.4	5.6	−51.0%
2019	61.0	37.7	-18.4	-6.8	-10.3	11.5	-25.9	-19.6	1.5	4.6	9.6	43.0	+66.9%
2018	3.4	40.8	-7.9	-13.3	11.6	4.6	2.3	8.8	-3.3	-12.2	-14.4	-8.0	+0.9%
2017	-4.0	-13.6	-7.5	-34.5	13.3	14.4	23.9	3.1	16.1	32.9	57.5	79.8	+263.6%
2016	-6.2	3.7	14.4	3.8	-39.5	-6.0	72.7	5.3	5.8	-12.1	-44.1	-57.7	−73.7%
2015											-26.8	-20.2	−41.6%

INSD

Insider Activity · AVTX

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

586.2K shares

Sells, 6 months

367.7K shares

Net shares

+218.5K

Net change in insider shares

+31.80%

Date	Insider	Transaction	Shares	Value
Sep 9, 2026	Sullivan Christopher RyanChief Financial Officer	Sale at price 17.62 per share.	10.2K	$179.46K
Sep 9, 2026	Sullivan Christopher RyanChief Financial Officer	Conversion of Exercise of derivative security at price 8.04 per share.	10.2K	$81.89K
Aug 27, 2026	Doyle MittieOfficer	Sale at price 20.00 per share.	679	$13.58K
Aug 27, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 8.04 per share.	679	$5.46K
Aug 17, 2026	Sullivan Christopher RyanChief Financial Officer	Sale at price 19.85 - 20.05 per share.	72.7K	$1.45M
Aug 17, 2026	Sullivan Christopher RyanChief Financial Officer	Conversion of Exercise of derivative security at price 9.88 per share.	71.9K	$709.90K
Aug 16, 2026	Doyle MittieOfficer	Sale at price 20.00 per share.	1K	$20.00K
Aug 16, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 12.65 per share.	1K	$12.65K
Aug 10, 2026	Riley JenniferOfficer	Sale at price 19.59 per share.	2.7K	$52.01K
Aug 9, 2026	Doyle MittieOfficer	Sale at price 20.00 per share.	679	$13.58K
Aug 9, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 8.04 per share.	679	$5.46K
Jul 26, 2026	Doyle MittieOfficer	Sale at price 20.00 per share.	1K	$20.00K
Jul 26, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 12.65 per share.	1K	$12.65K
Jun 29, 2026	Doyle MittieOfficer	Sale at price 20.00 per share.	4.7K	$93.08K
Jun 29, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 8.04 - 12.65 per share.	4.7K	$50.67K
Jun 22, 2026	Doyle MittieOfficer	Sale at price 18.00 per share.	1.4K	$26.10K
Jun 22, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 8.04 per share.	1.4K	$11.66K
May 27, 2026	Doyle MittieOfficer	Sale at price 16.00 per share.	679	$10.86K
May 27, 2026	Doyle MittieOfficer	Conversion of Exercise of derivative security at price 8.04 per share.	679	$5.46K
May 20, 2026	Neil Garry A. M.D.Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	100.2K	—

13F

Investors Holding AVTX

latest 13F filings of 29 followed managers

Investors holding AVTX
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$6.6M	0.01%	357.20K	+197%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

AVTX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

AVTX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Avalo Therapeutics, Inc.

Seasonality · AVTX

Insider Activity · AVTX

Congress Trades · AVTX

Investors Holding AVTX

Investors Holding AVTX

Congress Trades · AVTX

Insider Activity · AVTX

Seasonality · AVTX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Avalo Therapeutics, Inc.

Financial Snapshot

Earnings & Dividends

News